Eric J. Fues and Kyle W. Howarth of Finnegan discuss decisions exploring the multi-pronged analysis in patent law for ...
U.S. President Donald Trump has nominated John Squires, the former chief intellectual property attorney at banking giant ...
The nation’s highest patent court will rehear a case Thursday asking it to restrict the kinds of evidence expert witnesses ...
Welcome back to the Big Law Business column. I’m Roy Strom, and today we look at how looming changes in Washington are ...
How does the expiration of the patents in one jurisdiction impact global royalty payments? This question was addressed by the United States Court ...
In a precedential opinion issued on March 6, the Federal Circuit affirmed the US District Court for the Eastern District of Virginia that the claims in ImmunoGen’s US patent application 14/509,809 ...
GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...
Background: ImmunoGen’s Patent Application & Dispute. In 2014, ImmunoGen, Inc. (Immunogen) filed U.S. Patent Application No.
Freshfields represented Moderna, while Taylor Wessing advised BioNTech and Munich IP-firm df-mp was counsel to Pfizer.
Apple and health technology company AliveCor have been embroiled in multiple legal battles for years, including a ...
Retail Insight Network on MSN2d
US jury finds Lululemon’s athletic shoes violate Nike’s patent rightsA New York federal court jury awarded $355,450 in damages to Nike as a reasonable royalty on Lululemon's sales.
1d
In the first week of the year at the Federal Circuit, four Wilmer partners handled six arguments—a full 20% of the court’s argument calendar during that stretch. The firm scored wins in all six cases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback